Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04335799 · ClinicalTrials.gov registry record · NA
Reducing Weight and Elevated Stress Levels Using Educational and Behavioral Tools
A NA study of Obesity, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- Active
- Registry status
- NA
- Development phase
- 341
- Enrollment target
- 1
- Study location
NCT04335799: Active NA study of Obesity, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
NCT04335799 is a NA study of Obesity that is active but no longer recruiting, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 341 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (58% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04335799, a NA study of Obesity, is active but no longer recruiting, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 341 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this protocol is to test the effects on weight of an evidence-based behavioral weight loss program enhanced with culturally targeted stress management strategies compared to the evidence-based weight loss program alone among adult black females with obesity and elevated stress levels. Participants will be randomized to receive either a behavioral weight loss intervention with a focus on stress management or the weight loss intervention alone for 26 sessions.
Primary Outcome
weight change as measured by a SECA scale in kilograms and baseline and month 4 will be calculated and averaged
Conditions Studied
Interventions
- BEHAVIORAL Diabetes Prevention Program Intensive Lifestyle Intervention plus stress management training
- BEHAVIORAL Diabetes Prevention Program Intensive Lifestyle Intervention plus general women's health topics
Study Locations (1)
Florida
- Moffitt Cancer Center - Tampa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 341 participants |
| Start Date | 2021-10-12 |
| Est. Completion | 2027-03-31 |
| Phase | NA |
What the registry record for NCT04335799 still lists
NCT04335799 is an interventional study that assigns participants to a tested intervention. The registered 341 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (58% lower).
The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Diabetes Prevention Program Intensive Lifestyle Intervention plus stress management training is the first listed.
NCT04335799 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT04335799 about?
NCT04335799 is a clinical study titled "Reducing Weight and Elevated Stress Levels Using Educational and Behavioral Tools". The purpose of this protocol is to test the effects on weight of an evidence-based behavioral weight loss program enhanced with culturally targeted stress management strategies compared to the evidence-based weight loss program alone among adult black females with obesity and elevated stress levels....
What is the current status of trial NCT04335799?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 341 participants. The study started on 2021-10-12. Estimated completion is 2027-03-31.
What conditions does trial NCT04335799 study?
This clinical trial studies the following conditions: Obesity.
What interventions are being tested in trial NCT04335799?
The interventions under investigation include: Diabetes Prevention Program Intensive Lifestyle Intervention plus stress management training (BEHAVIORAL), Diabetes Prevention Program Intensive Lifestyle Intervention plus general women's health topics (BEHAVIORAL).
Who is sponsoring clinical trial NCT04335799?
This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04335799 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04335799's enrollment target sits among peer trials
341 194th of 1053 higher than 860 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
-
Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG)
RECRUITING · NA
-
SMARTer Weight Loss Management
RECRUITING · NA
-
HealthyTogether: RCT of a Dyadic Weight Management Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06852170 · 341 participants · NA
Data2Action Oregon Project: Supporting Data-driven Decision-Making for Substance Use Services, Policy, and Overdose Prevention
- NCT05283850 · 342 participants · Phase 2
Surviving PEA in Roanoke (SPEAR) Study
- NCT05714085 · 342 participants · Phase 2
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
- NCT06188702 · 342 participants · Phase 1
S095035 as a Single Agent and in Combination in Adult Participants With Advanced or Metastatic Solid Tumors With Deletion of MTAP
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI